Year archive

BioLineRx Ltd. — 2021 filings

All 85 regulatory filings released by BioLineRx Ltd. (BLRX) in 2021, sourced directly from the official regulator.

85 Filings

2021 Period

2021 filings (85)

Filing	Released	Lang
BioLineRx Provides Highlights from Oral Presentation Delivered at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition Regulatory Filings	2021-12-17	English
BioLineRx Provides Highlights from Oral Presentation Delivered at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition Report Publication Announcement	2021-12-17	English
6-K Regulatory Filings	2021-12-17	English
6-K Regulatory Filings	2021-12-15	English
BioLineRx Announces Formation of Immuno-Oncology Scientific Advisory Board (SAB) Regulatory Filings	2021-12-15	English
BioLineRx Announces Formation of Immuno-Oncology Scientific Advisory Board (SAB) Report Publication Announcement	2021-12-15	English
BioLineRx reports results of shareholders meeting which was held on December 2, 2021 AGM Information	2021-12-04	English
BioLineRx reports results of shareholders meeting which was held on December 2, 2021 AGM Information	2021-12-04	English
6-K Declaration of Voting Results & Voting Rights Announcements	2021-12-03	English
6-K Interim / Quarterly Report	2021-11-18	English
BioLineRx Reports Third Quarter 2021 Financial Results and Provides Corporate Update- FORM 6-K Interim / Quarterly Report Q3 2021	2021-11-18	English
BioLineRx Reports Third Quarter 2021 Financial Results and Provides Corporate Update- FORM 6-K Report Publication Announcement	2021-11-18	English
6-K Regulatory Filings	2021-11-04	English
BioLineRx Announces an Oral Presentation and Three Poster Presentations at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition Regulatory Filings	2021-11-04	English
BioLineRx Announces an Oral Presentation and Three Poster Presentations at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition Report Publication Announcement	2021-11-04	English
Immediate Report of Meeting to be held on December 2,2021,Proxy AGM Information	2021-10-28	English
Immediate Report of Meeting to be held on December 2,2021,Proxy AGM Information	2021-10-28	English
6-K AGM Information	2021-10-27	English
6-K Regulatory Filings	2021-10-13	English
BioLineRx Announces Positive Results from Pharmacoeconomic Study Positioning Motixafortide as Potential Standard of Care in Stem Cell Mobilization Regulatory Filings	2021-10-13	English
BioLineRx Announces Positive Results from Pharmacoeconomic Study Positioning Motixafortide as Potential Standard of Care in Stem Cell Mobilization Report Publication Announcement	2021-10-13	English
Regulatory Filings 2021 Regulatory Filings	2021-09-21	English
BioLineRx enters into At-The-Market Agreement with H.C. Wainwright & Co., LLC Regulatory Filings	2021-09-05	English
BioLineRx enters into At-The-Market Agreement with H.C. Wainwright & Co., LLC Regulatory Filings	2021-09-05	English
PROSPECTUS SUPPLEMENT – ATM Capital/Financing Update	2021-09-05	English
PROSPECTUS SUPPLEMENT – ATM Report Publication Announcement	2021-09-05	English
6-K Capital/Financing Update	2021-09-03	English
424B5 Capital/Financing Update	2021-09-03	English
COVER Interim / Quarterly Report	2021-08-18	English
BioLineRx Reports Second Quarter 2021 Financial Results and Provides Corporate Update Earnings Release Q2 2021	2021-08-18	English
BioLineRx Reports Second Quarter 2021 Financial Results and Provides Corporate Update Report Publication Announcement H1 2021	2021-08-18	English
6-K Interim / Quarterly Report	2021-05-26	English
BioLineRx Reports First Quarter 2021 Financial Results and Provides Corporate Update Interim / Quarterly Report Q1 2021	2021-05-26	English
BioLineRx Reports First Quarter 2021 Financial Results and Provides Corporate Update Report Publication Announcement	2021-05-26	English
6-K Regulatory Filings	2021-05-04	English
Positive Top-Line Results from GENESIS Phase 3 Trial of Motixafortide in Stem-Cell Mobilization for Autologous Bone Marrow Transplantation in Multiple Myeloma Patients Regulatory Filings	2021-05-04	English
Positive Top-Line Results from GENESIS Phase 3 Trial of Motixafortide in Stem-Cell Mobilization for Autologous Bone Marrow Transplantation in Multiple Myeloma Patients Report Publication Announcement	2021-05-04	English
BioLineRx Announces Presentation at 2021 American Association for Cancer Research (AACR) Annual Meeting Regulatory Filings	2021-04-17	English
BioLineRx Announces Presentation at 2021 American Association for Cancer Research (AACR) Annual Meeting Report Publication Announcement	2021-04-17	English
6-K Regulatory Filings	2021-04-15	English
Results of Extraordinary General Meeting of Shareholders which was held on April 5, 2021 Declaration of Voting Results & Voting Rights Announcements	2021-04-05	English
Results of Extraordinary General Meeting of Shareholders which was held on April 5, 2021 Declaration of Voting Results & Voting Rights Announcements	2021-04-05	English
6-K Declaration of Voting Results & Voting Rights Announcements	2021-04-05	English
Immediate Report of Meeting to be held on April 5, 2021,proxy statement Proxy Solicitation & Information Statement	2021-02-27	English
Immediate Report of Meeting to be held on April 5, 2021,proxy statement Proxy Solicitation & Information Statement	2021-02-27	English
Immediate Report of Meeting to be held on April 5, 2021,proxy statement AGM Information	2021-02-27	English
6-K Proxy Solicitation & Information Statement	2021-02-26	English
Regulatory Filings 2021 Regulatory Filings	2021-02-25	English
POS AM Regulatory Filings	2021-02-23	English
6-K Regulatory Filings	2021-02-23	English
20-F Annual Report FY 2020	2021-02-23	English
Post-Effective Amendment No.2 Capital/Financing Update	2021-02-23	English
Post-Effective Amendment No.2 Capital/Financing Update	2021-02-23	English
Form 20-F 2020 Annual Report FY 2020	2021-02-23	English
Form 20-F 2020 Report Publication Announcement	2021-02-23	English
Reports Year-End 2020 Financial Results and Provides Corporate Update Regulatory Filings	2021-02-23	English
Reports Year-End 2020 Financial Results and Provides Corporate Update Report Publication Announcement	2021-02-23	English
SC 13G/A Major Shareholding Notification	2021-02-16	English
AMENDMENT TO SCHEDULE 13G Major Shareholding Notification	2021-02-13	English
BIOLINERX LTD. Major Shareholding Notification	2021-02-12	English
AMENDMENT NO. 1 TO SCHEDULE 13G Major Shareholding Notification	2021-01-29	English
PRELIMINARY PROSPECTUS SUPPLEMENT dated January 11, 2021 Capital/Financing Update	2021-01-23	English
PRELIMINARY PROSPECTUS SUPPLEMENT dated January 11, 2021 Capital/Financing Update	2021-01-23	English
Closing of $34.5 Million Bought Deal Offering and Full Exercise of the Option of the Underwriter Regulatory Filings	2021-01-23	English
Closing of $34.5 Million Bought Deal Offering and Full Exercise of the Option of the Underwriter Report Publication Announcement	2021-01-23	English
6-K Regulatory Filings	2021-01-22	English
6-K Capital/Financing Update	2021-01-21	English
424B5 Capital/Financing Update	2021-01-21	English
BioLineRx Increases Previously Announced Bought Deal Offering to $30 Million Share Issue/Capital Change	2021-01-20	English
BioLineRx Increases Previously Announced Bought Deal Offering to $30 Million Capital/Financing Update	2021-01-20	English
FWP Capital/Financing Update	2021-01-20	English
Preliminary Prospectus Supplement (to prospectus dated January 11, 2021) Capital/Financing Update	2021-01-19	English
Preliminary Prospectus Supplement (to prospectus dated January 11, 2021) Regulatory Filings	2021-01-19	English
Announces $10 Million Bought Deal Offering Capital/Financing Update	2021-01-19	English
Announces $10 Million Bought Deal Offering Capital/Financing Update	2021-01-19	English
FWP Capital/Financing Update	2021-01-19	English
424B5 Capital/Financing Update	2021-01-19	English
Regulatory Filings 2021 Regulatory Filings	2021-01-12	English
Regulatory Filings 2021 Regulatory Filings	2021-01-11	English
SABBY 13G-A BLRX 1.06.21 Major Shareholding Notification	2021-01-06	English
Regulatory Filings 2021 Regulatory Filings	2021-01-06	English
PROSPECTUS SUPPLEMENT Dated December 31, 2020 Capital/Financing Update	2021-01-02	English
PROSPECTUS SUPPLEMENT Dated December 31, 2020 Report Publication Announcement	2021-01-02	English
Shelf Registration Statement Capital/Financing Update	2021-01-02	English
Shelf Registration Statement Capital/Financing Update	2021-01-02	English

Filings by year

2026 31 filings
2025 52 filings
2024 83 filings
2023 63 filings
2022 74 filings
2021 85 filings
2020 136 filings
2019 90 filings
2018 104 filings
2017 152 filings
2016 106 filings
2015 140 filings
2014 159 filings
2013 168 filings
2012 167 filings
2011 65 filings
2010 1 filing